P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy
- PMID: 11558784
- DOI: 10.1002/ana.1129
P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy
Abstract
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is widely regarded as an autoimmune disorder, although the autoantigen remains unknown. In this study, the sera of 21 CIDP patients were examined by immunofluorescence for antimyelin activity and by Western blotting for binding to myelin proteins. Six sera contained anti-P0 immunoglobulin G antibodies, and four of these caused conduction block and demyelination following intraneural injection in experimental animals. Absorption with P0 protein eliminated the demyelinating activity. These results show that P0 is an autoantigen in some patients with CIDP. Since P0 possesses powerful adhesion properties and is largely responsible for myelin compaction, the demonstration of demyelination by human anti-P0 antibodies provides new insight into this important and common immunopathological process.
Comment in
-
Chronic inflammatory demyelinating polyradiculoneuropathy.Ann Neurol. 2001 Sep;50(3):281-2. doi: 10.1002/ana.1142. Ann Neurol. 2001. PMID: 11558782 No abstract available.
Similar articles
-
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1431-9. doi: 10.1136/jnnp.2004.052282. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170091 Free PMC article.
-
Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy.J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):333-8. doi: 10.1136/jnnp.2008.159798. Epub 2008 Nov 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 19015227
-
Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.J Neurol Neurosurg Psychiatry. 2007 Apr;78(4):419-22. doi: 10.1136/jnnp.2006.106617. Epub 2006 Dec 8. J Neurol Neurosurg Psychiatry. 2007. PMID: 17158557 Free PMC article.
-
Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.J Peripher Nerv Syst. 2006 Mar;11(1):30-46. doi: 10.1111/j.1085-9489.2006.00061.x. J Peripher Nerv Syst. 2006. PMID: 16519780 Review.
-
[Biochemical features of chronic inflammatory demyelinating polyradiculoneuropathy].Rev Neurol (Paris). 2006 Apr;162(4):533-8. doi: 10.1016/s0035-3787(06)75047-0. Rev Neurol (Paris). 2006. PMID: 16585917 Review. French.
Cited by
-
Systematic reviews of treatment for inflammatory demyelinating neuropathy.J Anat. 2002 Apr;200(4):331-9. doi: 10.1046/j.1469-7580.2002.00041.x. J Anat. 2002. PMID: 12090400 Free PMC article. Review.
-
Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Nat Rev Neurol. 2017 Sep;13(9):533-547. doi: 10.1038/nrneurol.2017.84. Epub 2017 Jul 14. Nat Rev Neurol. 2017. PMID: 28708133 Review.
-
Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy.Curr Allergy Asthma Rep. 2007 Jul;7(4):274-9. doi: 10.1007/s11882-007-0041-z. Curr Allergy Asthma Rep. 2007. PMID: 17547849 Review.
-
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1431-9. doi: 10.1136/jnnp.2004.052282. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170091 Free PMC article.
-
Role of immune cells in animal models for inherited neuropathies: facts and visions.J Anat. 2002 Apr;200(4):405-14. doi: 10.1046/j.1469-7580.2002.00045.x. J Anat. 2002. PMID: 12090406 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
